Previous Article | Next Article 
Applied and Environmental Microbiology, April 2000, p. 1379-1384, Vol. 66, No. 4
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of a Novel
-Galactosidase from
Bifidobacterium adolescentis DSM 20083 Active towards
Transgalactooligosaccharides
Katrien M. J.
Van
Laere,1
Tjakko
Abee,2
Henk A.
Schols,1
Gerrit
Beldman,1 and
Alphons
G. J.
Voragen1,*
Laboratories for Food
Chemistry1 and Food
Microbiology,2 Department of Food Technology
and Nutritional Sciences, Wageningen University, Wageningen, The
Netherlands
Received 19 July 1999/Accepted 19 January 2000
 |
ABSTRACT |
This paper reports on the effects of both reducing and nonreducing
transgalactooligosaccharides (TOS) comprising 2 to 8 residues on the
growth of Bifidobacterium adolescentis DSM 20083 and on the
production of a novel
-galactosidase (
-Gal II). In cells grown on
TOS, in addition to the lactose-degrading
-Gal (
-Gal I), another
-Gal (
-Gal II) was detected and it showed activity towards TOS
but not towards lactose.
-Gal II activity was at least 20-fold
higher when cells were grown on TOS than when cells were grown on
galactose, glucose, and lactose. Subsequently, the enzyme was purified
from the cell extract of TOS-grown B. adolescentis by
anion-exchange chromatography, adsorption chromatography, and size-exclusion chromatography.
-Gal II has apparent molecular masses
of 350 and 89 kDa as judged by size-exclusion chromatography and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, respectively,
indicating that the enzyme is active in vivo as a tetramer.
-Gal II
had an optimal activity at pH 6 and was not active below pH 5. Its
optimum temperature was 35°C. The enzyme showed highest
Vmax values towards galactooligosaccharides
with a low degree of polymerization. This result is in agreement with the observation that during fermentation of TOS, the di- and
trisaccharides were fermented first.
-Gal II was active towards
-galactosyl residues that were 1
4, 1
6, 1
3, and 1
1
linked, signifying its role in the metabolism of
galactooligosaccharides by B. adolescentis.
 |
INTRODUCTION |
The human colonic flora has both
beneficial and pathogenic potential with respect to host health. There
is now much interest in the manipulation of the microbiotic composition
of the colon in order to improve the potentially beneficial effects of
the microorganisms (10). Probiotics are live microbial
supplements which beneficially affect the host by improving its
intestinal microbial balance (7, 9) and have been used for
many years for this reason. As the viability of live bacteria in food
products and during transit through the gastrointestinal tract may be
variable, the concept of prebiotics has been developed. A prebiotic is
considered to affect the host beneficially by selectively stimulating
the growth and/or activity of one or a limited number of naturally present or introduced bacterial species in the colon. It has been claimed that this will also lead to an improvement in host health (11). Increasingly, probiotics and prebiotics are used in
combination and are called synbiotics (4, 7, 32).
Fructooligosaccharides are considered prebiotics (10), and
oral dosages of transgalactooligosaccharides (TOS) appear to result in
increased numbers of bifidobacteria in the human fecal flora (2,
12, 13). It is claimed that a high number of bifidobacteria is
beneficial for the health of the host. This may prevent colonization by
pathogens and may have positive effects on intestinal peristalsis, on
the immune system, in cancer prevention, on cholesterol metabolism, and
on carbohydrate metabolism in the colon (11, 17).
TOS are oligosaccharides produced by transgalactosylation of lactose
using a
-galactosidase (
-Gal). The linkage between the galactose
units and the components in the final product depend on the enzymes and
the conditions used in the reaction. The production and
characterization of these TOS have been described in various publications (19, 21, 25). Different linkages between
galactose and the reducing glucose unit have been identified, namely,
-D-Galp-(1
2)-D-Glcp,
-D-Galp-(1
3)-D-Glcp,
-D-Galp-(1
4)-D-Glcp,
and
-D-Galp-(1
2)-D-Glcp. Also, branched Glcp residues occur, whereas oligogalactose
fragments contain mainly 1
4 or 1
6 linkages (26, 33).
Recently, Fransen et al. (8) showed that nonreducing
galactooligosaccharides were also formed during transgalactosylation of lactose.
Up to now no information has been available about the contribution of
the various oligosaccharides in TOS to growth of
Bifidobacterium species, and nothing is known about their
effect on the synthesis and activities of enzymes involved in
oligosaccharide metabolism. Only artificial substrates, such as
para-nitrophenyl
-D-galactoside, have been
used to determine
-Gal activities in bifidobacteria (1, 5, 6,
22, 23, 27, 28). However, the use of such substrates does not
supply information about the number of enzymes involved and their
specificities. Using classical culture methods and also molecular
techniques, it was shown that Bifidobacterium adolescentis
is a major bifidobacterial species in the adult intestinal microflora
(16, 18). In this paper we focus on the fermentation of
various oligosaccharides in TOS by B. adolescentis. In
addition to a lactose-degrading
-Gal (
-Gal I), a novel
-Gal
(
-Gal II) involved in the degradation of TOS was purified and
characterized. The role of the enzyme in the metabolism of TOS by
B. adolescentis is discussed.
 |
MATERIALS AND METHODS |
Substrates.
TOS were obtained by transgalactosylation of
lactose with a
-Gal. The TOS mixture (Borculo Whey Products,
Borculo, The Netherlands) was partially purified using charcoal
chromatography in order to decrease the levels of mono- and
disaccharides. The enriched oligosaccharide mixture contained 99%
oligomers as well as some residual galactose, glucose, and lactose.
Enriched fractions containing
[
-D-Galp-(1
6)]n-D-Glcp
and
[
-D-Galp-(1
4)]n-D-Glcp
were obtained by fractionation of TOS from, respectively, Oligomate-50
(Yakult Pharmaceutical Co. Ltd.) and CUP-oligo (Nissin Sugar, Tokyo,
Japan). Enriched fractions containing
[
-D-Galp-(1
4)]n-D-Galp
(n = 1 to 3) were obtained by incubation of extracted
soy arabinogalactan with an endo-galactanase. After partial
purification, their structure was confirmed using nuclear magnetic
resonance spectroscopy.
[
-D-Galp-(1
4)]n-D-Glcp (n = 2 to 3) and
-D-Galp-(1
1)-D-Glcp
were purified and characterized as described by Fransen et al.
(8). 3' Fucosyllactose, lacto-N-fucopentaose I,
lacto-N-fucopentaose II, and
-D-Galp(1
6)-D-Galp
were obtained from Dextra Laboratories Ltd. (Reading, United Kingdom),
-D-Galp(1
3)-Araf was obtained
from ICN Biomedicals Inc. (Aurora, Ohio). p-Nitrophenyl (NP)-glycosides were obtained from Sigma (St. Louis, Mo.) or from Koch
and Light, Ltd. (Haverhill, United Kingdom). Lactulose was obtained
from Solvay (Weesp, The Netherlands). Melibiose was obtained from
Jansens Chimica (Beerse, Belgium). Other chemicals were of analytical
grade and obtained from commercial sources.
Bacterial strain, culture conditions, and oligosaccharide
fermentation.
B. adolescentis DSM 20083 was obtained from
the Deutsche Sammlung von Mikroorganismen und Zelkulturen GmbH
(Braunschweig, Germany). Cell extracts were prepared from B. adolescentis grown in M17 broth (Oxoid, Hampshire, England) for
48 h at 37°C in an anaerobic chamber with an atmosphere
consisting of CO2 (10%), H2 (10%), and
N2 (80%). The pH of the medium was adjusted to pH 6.5 with
KOH prior to sterilization. Sugars (TOS, melibiose, lactose, galactose,
and glucose) (0.5% [wt/vol] sugars in the M17 medium) were added
from filter-sterilized stock solutions.
Analysis of TOS.
TOS from Borculo Whey Products, Yakult, and
Nissin were fractionated by Bio-Gel P-2 gel size-exclusion
chromatography (100 by 2.6 cm with a 200/400 mesh (Bio-Rad) and with
the column thermostated at 60°C, using a Pharmacia Hiload system
equipped with a Pharmacia P50 pump. A Shodex RI-72 detector was used to
monitor the refractive index of the water used as the eluent (0.3 ml/min). The oligosaccharide compositions of various fractions were
established using high-performance anion-exchange chromatography
(HPAEC). For this purpose a Bio-LC system (Dionex, Sunnyvale, Calif.)
that included a quaternary gradient pump, an eluent degas (He) module,
and a 4- by 250-mm Carbopac PA100 column with matching guard column
(pulsed amperometric detection mode) was used. Samples (20 µl) were
injected into the system using a Spectra Physics (San Jose, Calif.)
SP8800 autosampler, and chromatograms were recorded using a PC 1000 system. The sodium acetate gradient (1 ml/min) in 100 mM NaOH was for 0 to 30 min with a linear gradient of 0 to 200 mM. The effluent was
monitored using a pulsed electrochemical detector detector containing a gold electrode with an Ag-AgCl reference electrode. The column was
washed for 5 min with 1 M sodium acetate and equilibrated again for 15 min with 100 mM NaOH before the next run was performed.
Preparation of cell extracts.
B. adolescentis DSM
20083 was grown as described previously, and the cells were harvested
by centrifugation (10,000 × g, 10 min, 4°C) upon
reaching the stationary phase. Cells were washed once in 20 mM
phosphate buffer (pH 6.5) and then resuspended in 10 ml of the same
buffer. Cells were disrupted on ice by sonic treatment (15 min; duty
cycle, 30%). Subsequently, the suspension was centrifuged at
10,000 × g for 10 min to remove nondisrupted cells and
the resulting supernatant was centrifuged at 30,000 × g for 60 min to pellet cell debris. The supernatants (enzyme extracts) were filter sterilized and assayed for enzyme activity. The
protein contents of the enzyme extracts were determined using the
method of Bradford (3) with bovine serum albumin as a standard.
Enzyme assays.
-Gal activity was measured by determining
the hydrolysis of p-NP-
-D-galactopyranoside
(PNPG) at 40°C after 60 min of incubation. The reaction mixture (125 µl) contained 75 µl of 50 mM phosphate buffer (pH 6), 25 µl of
0.1% PNPG solution, and 25 µl of cell extract. The increase in
adsorbance (405 nm) was measured. A unit of enzyme activity was defined
as 1 µmol of galactose liberated per min in 50 mM phosphate buffer
(pH 6) at 40°C. The molar extinction coefficient under these assay
conditions was 13,700 M
1 cm
1.
The hydrolytic activities of
-Gal on TOS and the different
oligosaccharides and polysaccharides were calculated from the amount of
galactose released as determined by HPAEC. The incubation was performed
at 40°C for 1 h, and the reaction mixture consisted of 100 µl
of 0.1% (wt/vol) substrate in 50 mM phosphate buffer (pH 6).
Production and purification of
-Gal II.
-Gal II was
purified from the crude enzyme extract from B. adolescentis
grown on 0.5% (wt/vol) TOS. Unless stated otherwise, all procedures
were carried out at room temperature. All buffers contained 0.01%
(wt/vol) sodium azide to prevent microbial growth. Collected fractions
were screened for protein content (A280 or the
Sedmak method) and for
-Gal activity.
The purification steps of the enzyme extract involved Bio-Gel HTP
hydroxyapatite (Bio-Rad Laboratories, Richmond, Calif.), Q-Sepharose,
Mono Q HR5/5, and Sephacryl S200 HR16/60. The last three columns were
from Pharmacia LKB Biotechnology, Uppsala, Sweden.
pH and temperature optimum of
-Gal II at the conditions
used.
The optimum temperature of
-Gal II was determined by
incubation of the
-Gal with 0.1% (wt/vol) TOS in 50 mM phosphate
buffer (pH 7) at 20, 30, 35, 40, 45, 50, 60°C for 1 h. The
optimum pH was determined by incubating the
-Gal with 0.1% (wt/vol)
TOS in citrate-phosphate buffer in a pH range of 2.5 to 8.0 for 1 h at 40°C.
Kinetic parameters of
-Gal II.
Different substrates
[PNPG, lactose,
-D-Galp-(1
4)-
-D-Galp-(1
4)-D-Glcp,
-D-Galp-(1
4)-
-D-Galp-(1
4)-
-D-Galp-(1
4)-D-Glcp,
-D-Galp-(1
4)-D-Galp,
-D-Galp-(1
4)-
-D-Galp-(1
4)-D-Galp,
or
-D-Galp-(1
4)-
-D-Galp-(1
4)-
-D-Galp-(1
4)-D-Galp]
with concentrations ranging from 0.1 to 30 mM in a 50 mM phosphate
buffer (200-µl total volume, pH 6.0) were incubated with
-Gal II
(0.025 µg of protein/200 µl) at 40°C for 1 h. The
Km and catalytic constant values were calculated
from the initial rates of the hydrolyses of oligosaccharides. Data
analysis for calculation of kinetic parameters, using nonlinear
regression, was performed with the Enzfitter program (Biosoft,
Cambridge, United Kingdom).
Gel electrophoresis.
Native electrophoresis and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) were carried
out with a PhastSystem (Pharmacia LKB Biotechnology) according to the
instructions of the supplier by using a 8 to 25% polyacrylamide gel or
a 10 to 15% polyacrylamide gel (Pharmacia LKB Biotechnology).
Activity staining in acrylamide gels.
Different enzyme
extracts each containing 2 µg of protein were loaded and
electrophoresed on a nondenaturing PAGE system (Pharmacia LKB
Biotechnology).
-Gal activity was detected by incubating the gel in
a 4' umbelliferyl
-Galactoside solution (1 mg/ml in 50 mM phosphate
buffer, pH 7). Fluorescent bands were visualized under UV light and
photographed after incubation for 5 and 60 min.
 |
RESULTS |
Composition of the TOS mixture.
The TOS mixture was composed
mainly of oligosaccharides (99%) and small amounts of residual
galactose (0.1%), glucose (0.3%), and lactose (0.6%). In order to
determine the degrees of polymerization of the oligosaccharides
present, the oligosaccharide mixture was subjected to size-exclusion
chromatography on a Bio-Gel P-2 column. Fractions corresponding to a
given peak were pooled and subjected to HPAEC. All fractions were found
to contain several components (data not shown) having the same degree
of polymerization (8). In Fig.
1 the HPAEC elution profile of the
complete TOS mixture is given and the degrees of polymerization of the
various peaks are indicated.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
HPAEC elution pattern of TOS. Numbers 1 to 8 indicate
monomers, dimers, trimers, tetramers, pentamers, hexamers, heptamers,
and octamers, respectively. Peaks 3a, 4a, and 5a have been identified
as 4' galactosyllactose, 4' galactosyl galactosyl lactose, and 4'
galactosyl galactosyl galactosyl lactose, respectively. Note that peak
areas do not supply information about the concentrations of the
oligosaccharides, since the response factors of the pulsed
electrochemical detector vary significantly with the various oligomers,
with lowest responses occurring with oligosaccharides with a high DP.
PAD, pulsed amperometric detection.
|
|
The TOS mixture contains 0.5, 2, 6, 17, 37, 27, 8.5, and 2% mono-,
di-, tri-, tetra-, penta-, hexa-, hepta-, and octamers, respectively,
as determined using a refractive index. The structures of the purified
oligosaccharides are described elsewhere (8).
Degradation of TOS by B. adolescentis.
B.
adolescentis grown in M17 containing glucose (0.5% [wt/vol])
(GM17) was transferred to fresh M17 medium (anaerobic, batch) containing 0.5% (wt/vol) TOS. The growth (optical density) and acidification (pH) of the culture were measured (Fig.
2), and residual TOS was analyzed using
HPAEC (Fig. 3). After a lag phase in
which no carbohydrates were fermented (Fig. 3A), exponential growth
occurred. At the beginning of this exponential growth phase only
monomeric material was fermented. At the end of the first exponential
growth phase dimeric material and part of the trimeric material were
fermented (Fig. 3B). Upon reaching an optical density of 0.6, a second
lag phase occurred. In the second exponential growth phase oligomers
with a DP of
3 were fermented (Fig. 3C), with the low-DP
oligosaccharides being fermented first. Some residual TOS was observed
after 50 h (Fig. 3D), which may have been due to inactivation of
the enzyme at the low pH value reached at this point of fermentation
(Fig. 2 and see below). When B. adolescentis was precultured
on TOS, no biphasic growth could be observed and the stationary phase
was reached within 30 h. These results suggest that cells have
adapted to metabolize TOS more efficiently.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Growth of B. adolescentis in M17 containing
0.5% (wt/vol) TOS. Cells were precultured in M17 containing 0.5%
(wt/vol) glucose. Arrows A to D indicate at which times samples were
taken for HPAEC analysis of TOS in the supernatant (see Fig. 3). OD,
optical density.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
HPAEC elution pattern of TOS fermented by B. adolescentis. Samples were taken at 14 h (A), 22 h (B),
40 h (C), and 50 h (D) (see Fig. 2). m1, m2, m3, and m4 are
components present in M17 broth. Numbers 1 to 8 indicate monomers,
dimers, trimers, tetramers, pentamers, hexamers, heptamers, and
octamers, respectively. Peaks 3a, 4a, and 5a have been identified as 4'
galactosyllactose, 4' galactosyl galactosyl lactose, and 4' galactosyl
galactosyl galactosyl lactose, respectively. PAD, pulsed amperometric
detection.
|
|
Glycosidase activities in B. adolescentis.
Subsequently, glycosidase activities in different cell extracts were
determined with PNPG as a substrate. Specific
-Gal activity was
highest in cells grown on TOS (Table 1).
Surprisingly, other glycosidase activities were also higher in
TOS-grown cells, including
-Gal,
-glucosidase,
-xylosidase,
and
-L-arabinofuranosidase. Although high levels of
glycosidases were present, no endo-glycanase activity could be
detected.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Specific enzyme activities in cell extracts from
B. adolescentis DSM 20083 grown in the presence of
different substrates
|
|
The activities of enzyme extracts from lactose- and TOS-grown cells
towards TOS-pentamer were analyzed by determining the release of
galactose residues (Fig. 4). The amount
of galactose released by the enzyme extract from TOS-grown cells was
approximately 20-fold higher than that with enzyme extract of
lactose-grown cells. Comparable low amounts of galactose were also
released with enzyme extracts from galactose- and glucose-grown cells
(data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 4.
HPAEC elution patterns of galactopentasaccharides before
(A) and after (B and C) degradation with the enzyme extracts of
B. adolescentis grown on lactose (B) and on TOS (C).
Galp, galactose; p, pentamers; O, oligosaccharides formed by
degradation of the galactopentasaccharides; PAD, pulsed amperometric
detection.
|
|
-Gal activities of enzyme extracts from galactose-, glucose-,
lactose-, and TOS-grown B. adolescentis were also assayed
after PAGE under nondenaturating conditions using 4' umbelliferyl
-galactoside as the substrate (Fig.
5). In extracts from galactose-,
glucose-, and lactose-grown cells one
-Gal band (
-Gal I) was
observed, whereas in extracts from TOS-grown cells, besides
-Gal I,
the band of which exhibited an increased intensity, a second
-Gal (
-Gal II) was detected. This second activity band was only faintly visible after prolonged incubation with cell extracts from galactose-, glucose-, and lactose-grown cells (data not shown), indicating that
this enzyme is indeed present at very low levels in cells grown on
sugars other than TOS (see below).

View larger version (84K):
[in this window]
[in a new window]
|
FIG. 5.
-Gal activity staining on a nondenaturing
polyacrylamide gel. Crude enzyme preparations of B. adolescentis DSM 20083 grown on galactose (lane 1), glucose (lane
2), lactose (lane 3), and TOS (lane 4), with each preparation
containing 2 µg of protein, were supplied to the gel. -Gal
activity was visualized under UV light after 5 min of incubation with a
4' umbelliferyl -galactoside solution.
|
|
Purification and characterization of
-Gal II.
B.
adolescentis was grown on M17 and TOS, and after reaching
stationary phase, cells were harvested and the enzyme extract was
prepared. No
-Gal activity could be detected in the culture supernatant. The enzyme extract contained 2 g of protein, and a
total
-galactosidase activity of 880 U towards PNPG was measured. Cell extract from B. adolescentis was fractionated using
Q-Sepharose, Bio-Gel HTP hydroxyapatite, Mono Q HR5/5, and Sephacryl
S200 HR16/60. The Q-Sepharose separation resulted in the separation of
two different
-Gal's (
-Gal I and
-Gal II). The
-Gal
II-containing fraction showed activity towards TOS and no activity
towards lactose, while the
-Gal I-containing fraction was active
towards lactose and not towards TOS. The TOS-active
-Gal II action
was purified further on a Sephacryl S200 column and MonoQ column, and
this resulted in an electrophoretically pure
-Gal II preparation
(not shown). The molecular mass was approximately 350 kDa, as estimated
using Superose 12. By sodium dodecyl sulfate-PAGE, a single protein band was found at 89 kDa, suggesting that the enzyme is active as a
tetramer in vivo.
Substrate specificity and kinetic experiments with
-Gal II.
Subsequently, substrate specificity and physicochemical properties of
-Gal II were determined. Using PNPG, the enzyme had a specific
activity of 5.5 U/mg and optimal activity at pH 6 and 35°C.
-Gal
II was tested on a range of substrates.
-Gal II was active towards
the nonreducing oligosaccharide
-D-Galp-(1
1)-D-Glcp and to the other oligosaccharides present in the mixture, including TOS
(with a DP of 8) (data not shown). Activity was also observed towards
the galactooligosaccharides of other origins, such as
-D-Galp-(1
3)-Araf,
-D-Galp-(1
6)-D-Galp,
[
-D-Galp-(1
6)]n-D-Glcp (n = 2 to 3), and
[
-D-Galp-(1
4)]n-D-Galp
(n = 1 to 3). The enzyme showed no detectable activity
towards lactose, lactulose, 3' fucosyllactose,
lacto-N-fucopentaose I, or lacto-N-fucopentaose II. Incubation of
-Gal II in assays with increasing concentrations of
1
4-linked galactooligosaccharides resulted in hyperbolic plots
of substrate versus reaction rate, indicating typical Michaelis-Menten saturation kinetics. Km and
Vmax values for the enzyme towards different
galactooligosaccharides and PNPG are given in Table 2. These data clearly show a general
decrease in the Vmax and catalytic efficiency
(expressed as Vmax/Km) of
-Gal II with an increase in the size of the oligosaccharides.
 |
DISCUSSION |
This paper reports on the isolation and characterization of a
novel
-Gal (
-Gal II) from B. adolescentis, active
towards TOS. B. adolescentis produces two different
-Gal's when it is cultured on TOS. The first one (
-Gal I), which
was also detected in cells grown on glucose, galactose, and lactose,
appeared to be active towards lactose but not towards TOS. The
TOS-active
-Gal II was present at high levels only in TOS-grown
cells, indicating that synthesis is induced by the substrate.
-Gal
II was subsequently characterized further and was optimally active at
pH 6 and 35°C, conditions mimicking those found in the colon.
Remarkably, purified
-Gal II showed no activity at pH 5 and below,
which may affect the action of the enzyme in environments such as the
colon, where the pH may decrease below pH 6 due to microbial production
of short-chain fatty acids.
-Gal II was active toward all the
oligosaccharides present in the TOS mixture, including those with high
DP. Kinetic characterization of
-Gal II revealed highest
Vmax values towards oligosaccharides with low
DP, which is in line with the sequential degradation observed during
TOS fermentation. The
-Gal II was also active towards
-galactooligosaccharides derived from soy. However,
-Gal II
showed no activity towards fucosylated galactooligosaccharides isolated
from human milk. The nonreducing disaccharide
-D-Galp-(1
1)-D-Glcp isolated by Fransen et al. (8) from the TOS mixture was
completely hydrolyzed into galactose and glucose monomers, indicating
that these novel types of nonreducing oligosaccharides can be degraded by B. adolescentis.
Since microbial sugar transport systems described so far can take up
monomers, dimers, or trimers (20), it is speculated that
-Gal II, in contrast to lactose-hydrolyzing
-Gal I, is located
extracellularly. It is conceivable that the enzyme is cell wall or
membrane attached, since no activity was found in the culture
supernatant. With TOS, extracellularly released galactose residues from
TOS by
-Gal II would be accumulated via a galactose transport system
and subsequently metabolized. The final remaining lactose may be taken
up via a lactose transport system (14, 20) and split
intracellularly by
-Gal I, and the galactose and glucose residues
may then metabolized. Several other B. adolescentis enzymes
active towards large extracellular substrates were not found in the
supernatant, which indicates that they are cell wall or membrane bound
(30, 31). The recently characterized (15) and
cloned (29)
-Gal showing activity towards
-galactooligosaccharides was shown to possess a signal sequence,
which indicates that the enzyme is translocated to and active on the
outside of the cell. Also, two arabinoxylan arabinofuranohydrolases
from B. adolescentis were supposed to be membrane or cell
wall associated and to degrade an extracellular substrate, as they are
active towards arabinose-containing xylooligosaccharides which contain
up to 10 sugar units (30, 31). Whether the binding of these
glycosidases to the cell wall provides a competitive advantage, e.g.,
in releasing substrates at the cell surface, remains to be elucidated.
The utilization of the trisaccharides 4' galactosyllactose and 6'
galactosyllactose by intestinal bacteria has been studied previously
(24), and it has been shown that these substrates are
fermented not only by bifidobacteria but also by
Lactobacillus, Bacteroides, and
Clostridium species. It is conceivable that these bacteria
produce
-Gal's active towards these trisaccharides. So far the
utilization of galactooligosaccharides with a higher degree of
polymerization has not been reported. Our work shows that B. adolescentis can degrade also oligosaccharides with a DP of >3
under these conditions. Other tested bacteria such as Bifidobacterium infantis and Lactobacillus
acidophilus could utilize only the TOS with a DP of
3 present in
the mixture (data not shown). Metabolism of high concentrations of TOS
by B. adolescentis is linked to the production of
-Gal
II, which is active towards these oligosaccharides. This enzyme might
allow B. adolescentis to utilize the oligosaccharides more
efficiently than other microorganisms. Therefore, this TOS mixture,
containing mainly higher-molecular-weight material, might be an
interesting prebiotic substrate, as it is metabolized by B. adolescentis, one of the predominant human fecal bacteria
(16).
Strikingly, during growth of B. adolescentis on TOS a large
number of glycosidases are produced, including two
arabinofuranohydrolases which are involved in the degradation of
arabinoxylooligosaccharides (30, 31). This may offer an
additional competitive advantage, since it allows the organism to
scavenge the environment for a range of substrates and use the
degradation products for growth. No endo-glycanase activity could be
detected in the cell extract (data not shown), suggesting that B. adolescentis adopted a strategy aimed at utilizing polysaccharide
degradation products generated by other microorganisms instead of
taking part in the initial depolymerization stage of polysaccharides.
The obtained results provide new insights into the oligosaccharide
metabolism of bifidobacteria. Furthermore, the induction of
-Gal II
during growth on TOS indicates that optimal performance of a synbiotic
product containing B. adolescentis (probiotic) and TOS
(prebiotic) can be obtained only by preculturing the microorganism on
this substrate.
 |
ACKNOWLEDGMENTS |
This work was supported by the Netherlands Ministry of
Agriculture, Nature Management and Fishery, The Dutch Dairy Foundation on Nutrition and Health, AVEBE, Nutreco (all in The Netherlands), and
ORAFTI (Belgium).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory for
Food Chemistry, Department of Food Technology and Nutritional Sciences, Wageningen University, Bomenweg 2, 6703 HD Wageningen, The Netherlands. Phone: 31-317-484811. Fax: 31-317-484893. E-mail:
Fons.Voragen{at}Chem.Fdsci.Wau.NL.
 |
REFERENCES |
| 1.
|
Blanchette, D. R. L.,
L. Savoie,
P. Ward, and P. Chevalier.
1992.
Alpha- and beta-galactosidase properties of Bifidobacterium infantis.
Milchwissenschaft
47:18-21.
|
| 2.
|
Bouhnik, Y.,
B. Flourie,
L. D'Agay,
Abensour,
P. Pochart,
G. Gramet,
M. Durand, and J. C. Rambaud.
1997.
Administration of transgalactooligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans.
J. Nutr.
127:444-448[Abstract/Free Full Text].
|
| 3.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 4.
|
Crittenden, R. G., and G. W. Tannock.
1999.
Prebiotics, p. 141-156.
In
G. W. Tannock (ed.), Probiotics: a critical review. Horizon Scientific Press, Wymondham, United Kingdom.
|
| 5.
|
Desjardins, M. L.,
D. Roy, and J. Goulet.
1990.
Growth of bifidobacteria and their enzyme profiles.
J. Dairy Sci.
73:299-307[Abstract].
|
| 6.
|
Dumortier, V.,
C. Brassart, and S. Bouquelet.
1994.
Purification and properties of a beta-D-galactosidase from Bifidobacterium bifidum exhibiting a transgalactosylation reaction.
Biotechnol. Appl. Biochem.
19:341-354.
|
| 7.
|
Fooks, L. J.,
R. Fuller, and G. R. Gibson.
1999.
Prebiotics, probiotics and human gut microbiology.
Int. Dairy J.
9:53-61.
|
| 8.
|
Fransen, C. T. M.,
K. M. J. Van Laere,
A. A. C. van Wijk,
L. P. B. Brüll,
M. Dignum,
J. E. T. Thomas-Oates,
J. Haverkamp,
H. A. Schols,
A. G. J. Voragen,
J. P. Kamerling, and J. F. G. Vliegenthart.
1998.
-D-Glcp-(1 1)- -D-Galp-containing oligosaccharides, a new class of oligosaccharides produced by -galactosidase from lactose.
Carbohydr. Res.
314:101-114[Medline].
|
| 9.
|
Fuller, R.
1989.
Probiotics in man and animals.
J. Appl. Bacteriol.
66:365-378[Medline].
|
| 10.
|
Gibson, G. R.
1998.
Dietary modulation of the human gut microflora using prebiotics.
Br. J. Nutr.
80:S209-S212[Medline].
|
| 11.
|
Gibson, G. R., and M. B. Roberfroid.
1995.
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.
J. Nutr.
125:1401-1412.
|
| 12.
|
Ito, M.,
Y. Deguchi,
A. Miyamori,
K. Matsuomote,
H. Kikuchi,
K. Matsumoto,
T. Yajima, and T. Kan.
1990.
Effect of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation.
Microb. Ecol. Health Dis.
3:285-292.
|
| 13.
|
Ito, M.,
Y. Deguchi,
K. Matsumoto,
M. Kimura,
N. Onodera, and T. Yajima.
1993.
Influence of galactooligosaccharides on the human fecal microflora.
J. Nutr. Sci. Vitaminol.
39:635-640.
|
| 14.
|
Krzewinski, F.,
C. Brassart,
F. Gavini, and S. Bouquelet.
1996.
Characterization of the lactose transport system in the strain Bifidobacterium bifidum DSM 20082.
Curr. Microbiol.
32:301-307[CrossRef][Medline].
|
| 15.
|
Leder, S.,
W. Hartmeier, and S. P. Marx.
1999.
-Galactosidase of Bifidobacterium adolescentis DSM 20083.
Curr. Microbiol.
38:101-106[CrossRef][Medline].
|
| 16.
|
Matsuki, T.,
K. Watanabe,
R. Tanaka,
M. Fukuda, and H. Oyaizu.
1999.
Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers.
Appl. Environ. Microbiol.
65:4506-4512[Abstract/Free Full Text].
|
| 17.
|
Mitsuoka, T.
1990.
Bifidobacteria and their role in human health.
J. Ind. Microbiol.
6:263-268[CrossRef].
|
| 18.
|
Mutai, M., and R. Tanaka.
1987.
Ecology of Bifidobacterium in the human intestinal flora.
Bifidobacteria Microflora
6:33-41.
|
| 19.
|
Onishi, N., and T. Tanaka.
1997.
Purification and characterization of galactooligosaccharide-producing beta-galactosidase from Sirobasidium magnum.
Lett. Appl. Microbiol.
24:82-86.
|
| 20.
|
Poolman, B.
1993.
Energy transduction in lactic acid bacteria.
FEMS Microbiol. Rev.
12:125-148[CrossRef][Medline].
|
| 21.
|
Prenosil, J. E.,
E. Stuker, and J. R. Bourne.
1987.
Formation of oligosaccharides during enzymatic lactose hydrolysis. I. State of the art.
Biotechnol. Bioeng.
30:1019-1025[CrossRef].
|
| 22.
|
Roy, D.,
J. L. Berger, and G. Reuter.
1994.
Characterization of dairy-related Bifidobacterium spp. based on their beta-galactosidase electrophoretic patterns.
Int. J. Food Microbiol.
23:55-70[CrossRef][Medline].
|
| 23.
|
Roy, D.,
L. Blanchette,
L. Savoie,
P. Ward, and P. Chevalier.
1992.
alpha- and beta-galactosidase properties of Bifidobacterium infantis.
Milchwissenschaft
47:18-21.
|
| 24.
|
Sako, T.,
K. Matsumoto, and R. Tanaka.
1999.
Recent progress on research and applications of non-digestible galactooligosaccharides.
Int. Dairy J.
9:69-80.
|
| 25.
|
Smart, J. B.
1991.
Transferase reactions of the beta-galactosidase from Streptococcus thermophilus.
Appl. Microbiol. Biotechnol.
34:495-501.
|
| 26.
|
Smart, J. B.
1993.
Transferase reactions of beta-galactosidases new product opportunities.
Bull. Int. Dairy Fed.
289:16-22.
|
| 27.
|
Smart, J. B.,
C. J. Pillidge, and J. H. Garman.
1993.
Growth of lactic acid bacteria and bifidobacteria on lactose and lactose-related mono-, di- and trisaccharides and correlation with distribution of beta-galactosidase and phospho-beta-galactosidase.
J. Dairy Res.
60:557-568.
|
| 28.
|
Tochikura, T.,
K. Saka,
T. Fujiyoshi,
T. Tachiki, and H. Kumagai.
1986.
p-Nitrophenyl glycoside-hydrolysing activities in bifidobacteria and characterisation of -D-galactosidase of Bifidobacterium longum 401.
Agric. Biol. Chem.
50:2279-2286.
|
| 29.
|
van den Broek, L. A. M.,
J. Ton,
J. C. Verdoes,
K. M. J. Van Laere,
A. G. J. Voragen, and G. Beldman.
1999.
Synthesis of -galactooligosaccharides by a cloned -galactosidase from Bifidobacterium adolescentis.
Biotechnol. Lett.
21:441-445[CrossRef].
|
| 30.
|
Van Laere, K. M. J.,
C. H. L. Voragen,
T. Kroef,
L. A. M. van den Broek,
G. Beldman, and A. G. J. Voragen.
1999.
Purification and mode of action of two different arabinoxylan arabinofuranohydrolases from Bifidobacterium adolescentis.
Appl. Microbiol. Biotechnol.
51:606-613[CrossRef].
|
| 31.
|
Van Laere, K. M. J.,
G. Beldman, and A. G. J. Voragen.
1997.
A new arabinofuranohydrolase from Bifidobacterium adolescentis able to remove arabinosyl residues from double-substituted xylose units in arabinoxylan.
Appl. Microbiol. Biotechnol.
47:231-235[CrossRef][Medline].
|
| 32.
|
Walker, W. A., and L. C. Duffy.
1998.
Diet and bacterial colonization: role of probiotics and prebiotics.
J. Nutr. Biochem.
9:668-675[CrossRef].
|
| 33.
|
Zarate, S., and M. H. Lopez-Leiva.
1990.
Oligosaccharide formation during enzymatic lactose hydrolysis: a literature review.
J. Food Prot.
53:262-268.
|
Applied and Environmental Microbiology, April 2000, p. 1379-1384, Vol. 66, No. 4
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Amaretti, A., Bernardi, T., Tamburini, E., Zanoni, S., Lomma, M., Matteuzzi, D., Rossi, M.
(2007). Kinetics and Metabolism of Bifidobacterium adolescentis MB 239 Growing on Glucose, Galactose, Lactose, and Galactooligosaccharides. Appl. Environ. Microbiol.
73: 3637-3644
[Abstract]
[Full Text]
-
Shipkowski, S., Brenchley, J. E.
(2006). Bioinformatic, Genetic, and Biochemical Evidence that Some Glycoside Hydrolase Family 42 {beta}-Galactosidases Are Arabinogalactan Type I Oligomer Hydrolases. Appl. Environ. Microbiol.
72: 7730-7738
[Abstract]
[Full Text]
-
Janer, C., Arigoni, F., Lee, B. H., Pelaez, C., Requena, T.
(2005). Enzymatic Ability of Bifidobacterium animalis subsp. lactis To Hydrolyze Milk Proteins: Identification and Characterization of Endopeptidase O. Appl. Environ. Microbiol.
71: 8460-8465
[Abstract]
[Full Text]
-
Ruas-Madiedo, P., Hernandez-Barranco, A., Margolles, A., de los Reyes-Gavilan, C. G.
(2005). A Bile Salt-Resistant Derivative of Bifidobacterium animalis Has an Altered Fermentation Pattern When Grown on Glucose and Maltose. Appl. Environ. Microbiol.
71: 6564-6570
[Abstract]
[Full Text]
-
Hinz, S. W. A., Pastink, M. I., van den Broek, L. A. M., Vincken, J.-P., Voragen, A. G. J.
(2005). Bifidobacterium longum Endogalactanase Liberates Galactotriose from Type I Galactans. Appl. Environ. Microbiol.
71: 5501-5510
[Abstract]
[Full Text]
-
Van der Meulen, R., Avonts, L., De Vuyst, L.
(2004). Short Fractions of Oligofructose Are Preferentially Metabolized by Bifidobacterium animalis DN-173 010. Appl. Environ. Microbiol.
70: 1923-1930
[Abstract]
[Full Text]
-
Coker, J. A., Sheridan, P. P., Loveland-Curtze, J., Gutshall, K. R., Auman, A. J., Brenchley, J. E.
(2003). Biochemical Characterization of a {beta}-Galactosidase with a Low Temperature Optimum Obtained from an Antarctic Arthrobacter Isolate. J. Bacteriol.
185: 5473-5482
[Abstract]
[Full Text]
-
McBAIN, A.J., MACFARLANE, G.T.
(2001). Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems. J Med Microbiol
50: 833-842
[Abstract]
[Full Text]
-
Møller, P. L., Jørgensen, F., Hansen, O. C., Madsen, S. M., Stougaard, P.
(2001). Intra- and Extracellular {beta}-Galactosidases from Bifidobacterium bifidum and B. infantis: Molecular Cloning, Heterologous Expression, and Comparative Characterization. Appl. Environ. Microbiol.
67: 2276-2283
[Abstract]
[Full Text]